| Pharmaceutical active ingredients: |
| Fluocortolone PivalateLidocaine Hydrochloride |
| Available forms, composition and doses of Neoproct: |
| N / A |
| Neoproct medical category: |
| Human:Anorectal preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C05AA08 - FluocortoloneD07AC05 - FluocortoloneH02AB03 - Fluocortolone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bayer Schering Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Ultradil | Fluocortolone Caproate; Fluocortolone Pivalate | Bayer Schering Pharma; HE Clissmann |
| Ultradil Plain | Fluocortolone Caproate; Fluocortolone Pivalate | Bayer Schering Pharma |
| Omnilan | Fluocortolone Pivalate | Bayer Schering Pharma |
| Doloproct | Fluocortolone Pivalate; Lidocaine Hydrochloride | Bayer Schering Pharma; Invida; Zuellig Pharma |
| Doloprokt | Fluocortolone Pivalate; Lidocaine Hydrochloride | Intendis |
| Ultraproct N | Fluocortolone Pivalate; Lidocaine Hydrochloride | Bayer Schering Pharma; Intendis; Invida; The Glory Medicina; Transfarma Medica Indah |
| Pilison | Fluocortolone Pivalate; Salicylic Acid | Bayer Schering Pharma |
| Ultralan-Crinale | Fluocortolone Pivalate; Salicylic Acid | Bayer Schering Pharma |
| Ultracur S | Fluocortolone; Fluocortolone Caproate | Bayer Schering Pharma |
| Ultralanum | Fluocortolone; Fluocortolone Caproate; Fluocortolone Pivalate | Bayer Schering Pharma |